- Previous Close
24.12 - Open
24.18 - Bid 17.37 x 100
- Ask 30.59 x 200
- Day's Range
23.81 - 24.31 - 52 Week Range
19.50 - 33.97 - Volume
604,842 - Avg. Volume
1,300,271 - Market Cap (intraday)
3.056B - Beta (5Y Monthly) 2.73
- PE Ratio (TTM)
-- - EPS (TTM)
-1.33 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
31.91
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
www.surgerypartners.com15,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SGRY
View MorePerformance Overview: SGRY
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGRY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGRY
View MoreValuation Measures
Market Cap
3.06B
Enterprise Value
6.49B
Trailing P/E
--
Forward P/E
28.33
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.97
Price/Book (mrq)
1.71
Enterprise Value/Revenue
2.08
Enterprise Value/EBITDA
12.94
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.40%
Return on Assets (ttm)
4.01%
Return on Equity (ttm)
0.36%
Revenue (ttm)
3.11B
Net Income Avi to Common (ttm)
-168.1M
Diluted EPS (ttm)
-1.33
Balance Sheet and Cash Flow
Total Cash (mrq)
269.5M
Total Debt/Equity (mrq)
102.14%
Levered Free Cash Flow (ttm)
181.48M